AI Assistant
Blog
Pricing
Log In
Sign Up
High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings
Details
Cite
Export
Add to List
This content is not available in your region!
Continue researching
here.
